Koenraad De Geest

Professor

  • 7171 Citations
  • 42 h-Index
1984 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 7171 Citations
  • 42 h-Index
  • 91 Article
  • 3 Review article
  • 1 Comment/debate
Filter
Article
2019

The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study

Spirtos, N. M., Enserro, D., Homesley, H. D., Gibbons, S. K., Cella, D., Morris, R. T., DeGeest, K., Lee, R. B. & Miller, D. S., Jul 2019, In : Gynecologic oncology. 154, 1, p. 13-21 9 p.

Research output: Contribution to journalArticle

1 Scopus citations
2016
2 Scopus citations

SSRI use and clinical outcomes in epithelial ovarian cancer

Christensen, D. K., Armaiz-Pena, G. N., Ramirez, E., Matsuo, K., Zimmerman, B., Zand, B., Shinn, E., Goodheart, M. J., Bender, D., Thaker, P. H., Ahmed, A., Penedo, F. J., DeGeest, K., Mendez, L., Domann, F., Sood, A. K. & Lutgendorf, S. K., May 31 2016, In : Oncotarget. 7, 22, p. 33179-33191 13 p.

Research output: Contribution to journalArticle

6 Scopus citations
2015

Biobehavioral and neuroendocrine correlates of antioxidant enzyme activity in ovarian carcinoma

Bayer, J. L., Spitz, D. R., Christensen, D., McCormick, M. L., Farley, D., DeGeest, K., Damoush, L., Aust, S., Sood, A. K. & Lutgendorf, S. K., Nov 1 2015, In : Brain, Behavior, and Immunity. 50, p. 58-62 5 p.

Research output: Contribution to journalArticle

3 Scopus citations

Diurnal cortisol and survival in epithelial ovarian cancer

Schrepf, A., Thaker, P. H., Goodheart, M. J., Bender, D., Slavich, G. M., Dahmoush, L., Penedo, F., DeGeest, K., Mendez, L., Lubaroff, D. M., Cole, S. W., Sood, A. K. & Lutgendorf, S. K., Mar 1 2015, In : Psychoneuroendocrinology. 53, p. 256-267 12 p.

Research output: Contribution to journalArticle

47 Scopus citations
2014

Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Brown, J., Brady, W. E., Schink, J., Van Le, L., Leitao, M., Yamada, S. D., De Geest, K. & Gershenson, D. M., Feb 1 2014, In : Cancer. 120, 3, p. 344-351 8 p.

Research output: Contribution to journalArticle

39 Scopus citations

Focal adhesion kinase: An alternative focus for anti-angiogenesis therapy in ovarian cancer

Stone, R. L., Baggerly, K. A., Armaiz-Pena, G. N., Kang, Y., Sanguino, A. M., Thanapprapasr, D., Dalton, H. J., Bottsford-Miller, J., Zand, B., Akbani, R., Diao, L., Nick, A. M., DeGeest, K., Lopez-Berestein, G., Coleman, R. L., Lutgendorf, S. & Sood, A. K., Jul 2014, In : Cancer Biology and Therapy. 15, 7, p. 919-929 11 p.

Research output: Contribution to journalArticle

23 Scopus citations
2013

Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: Relationships with depression, fatigue, and disability

Schrepf, A., Clevenger, L., Christensen, D., DeGeest, K., Bender, D., Ahmed, A., Goodheart, M. J., Dahmoush, L., Penedo, F., Lucci, J. A., Ganjei-Azar, P., Mendez, L., Markon, K., Lubaroff, D. M., Thaker, P. H., Slavich, G. M., Sood, A. K. & Lutgendorf, S. K., Mar 15 2013, In : Brain, Behavior, and Immunity. 30, SUPPL., p. S126-S134

Research output: Contribution to journalArticle

56 Scopus citations

Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173

Coleman, R. L., Ali, S., Levenback, C. F., Gold, M. A., Fowler, J. M., Judson, P. L., Bell, M. C., De Geest, K., Spirtos, N. M., Potkul, R. K., Leitao, M. M., Bakkum-Gamez, J. N., Rossi, E. C., Lentz, S. S., Burke, J. J., Van Le, L. & Trimble, C. L., Feb 1 2013, In : Gynecologic oncology. 128, 2, p. 155-159 5 p.

Research output: Contribution to journalArticle

42 Scopus citations

Microvessel density and p53 mutations in advanced-stage epithelial ovarian cancer

Nadkarni, N. J., Geest, K. D., Neff, T., Young, B. D., Bender, D. P., Ahmed, A., Smith, B. J., Button, A. & Goodheart, M. J., Apr 30 2013, In : Cancer Letters. 331, 1, p. 99-104 6 p.

Research output: Contribution to journalArticle

17 Scopus citations

Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients

Lutgendorf, S. K., Slavich, G. M., Degeest, K., Goodheart, M., Bender, D., Thaker, P. H., Penedo, F., Zimmerman, B., Lucci, J., Mendez, L., Collins, K. & Sood, A. K., Dec 1 2013, In : Gynecologic oncology. 131, 3, p. 667-673 7 p.

Research output: Contribution to journalArticle

12 Scopus citations

Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis

Clevenger, L., Schrepf, A., Degeest, K., Bender, D., Goodheart, M., Ahmed, A., Dahmoush, L., Penedo, F., Lucci, J., Thaker, P. H., Mendez, L., Sood, A. K., Slavich, G. M. & Lutgendorf, S. K., Sep 1 2013, In : Cancer. 119, 17, p. 3234-3241 8 p.

Research output: Contribution to journalArticle

50 Scopus citations

Src activation by adrenoreceptors is a key switch for tumour metastasis

Armaiz-Pena, G. N., Allen, J. K., Cruz, A., Stone, R. L., Nick, A. M., Lin, Y. G., Han, L. Y., Mangala, L. S., Villares, G. J., Vivas-Mejia, P., Rodriguez-Aguayo, C., Nagaraja, A. S., Gharpure, K. M., Wu, Z., English, R. D., Soman, K. V., Shahzad, M. M. K., Zigler, M., Deavers, M. T., Zien, A. & 13 others, Soldatos, T. G., Jackson, D. B., Wiktorowicz, J. E., Torres-Lugo, M., Young, T., De Geest, K., Gallick, G. E., Bar-Eli, M., Lopez-Berestein, G., Cole, S. W., Lopez, G. E., Lutgendorf, S. K. & Sood, A. K., Jan 1 2013, In : Nature communications. 4, 1403.

Research output: Contribution to journalArticle

122 Scopus citations
2012

A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Gold, M. A., Brady, W. E., Lankes, H. A., Rose, P. G., Kelley, J. L., De Geest, K., Crispens, M. A., Resnick, K. E. & Howell, S. B., Jun 1 2012, In : Gynecologic oncology. 125, 3, p. 635-639 5 p.

Research output: Contribution to journalArticle

23 Scopus citations

A phase i trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study

Moore, K. N., Sill, M. W., Miller, D. S., McCourt, C., De Geest, K., Rose, P. G., Cardenes, H. R., Mannel, R. S., Farley, J. H., Schilder, R. J. & Fracasso, P. M., Dec 1 2012, In : Gynecologic oncology. 127, 3, p. 456-461 6 p.

Research output: Contribution to journalArticle

29 Scopus citations

Intraoperative autologous blood transfusion use during radical hysterectomy for cervical cancer: Long-term follow-up of a prospective trial

Engle, D. B., Connor, J. P., Morris, P. C., Bender, D. P., De Geest, K., Ahmed, A. & Goodheart, M. J., Sep 1 2012, In : Archives of Gynecology and Obstetrics. 286, 3, p. 717-721 5 p.

Research output: Contribution to journalArticle

7 Scopus citations

Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: A gynecologic oncology group study

Levenback, C. F., Ali, S., Coleman, R. L., Gold, M. A., Fowler, J. M., Judson, P. L., Bell, M. C., De Geest, K., Spirtos, N. M., Potkul, R. K., Leitao, M. M., Bakkum-Gamez, J. N., Rossi, E. C., Lentz, S. S., Burke, J. J., Van Le, L. & Trimble, C. L., Nov 1 2012, In : Journal of Clinical Oncology. 30, 31, p. 3786-3791 6 p.

Research output: Contribution to journalArticle

185 Scopus citations

Paraneoplastic thrombocytosis in ovarian cancer

Stone, R. L., Nick, A. M., McNeish, I. A., Balkwill, F., Han, H. D., Bottsford-Miller, J., Rupaimoole, R., Armaiz-Pena, G. N., Pecot, C. V., Coward, J., Deavers, M. T., Vasquez, H. G., Urbauer, D., Landen, C. N., Hu, W., Gershenson, H., Matsuo, K., Shahzad, M. M. K., King, E. R., Tekedereli, I. & 14 others, Ozpolat, B., Ahn, E. H., Bond, V. K., Wang, R., Drew, A. F., Gushiken, F., Lamkin, D., Collins, K., DeGeest, K., Lutgendorf, S. K., Chiu, W., Lopez-Berestein, G., Afshar-Kharghan, V. & Sood, A. K., Feb 16 2012, In : New England Journal of Medicine. 366, 7, p. 610-618 9 p.

Research output: Contribution to journalArticle

404 Scopus citations

Social influences on clinical outcomes of patients with ovarian cancer

Lutgendorf, S. K., De Geest, K., Bender, D., Ahmed, A., Goodheart, M. J., Dahmoush, L., Zimmerman, M. B., Penedo, F. J., Lucci, J. A., Ganjei-Azar, P., Thaker, P. H., Mendez, L., Lubaroff, D. M., Slavich, G. M., Cole, S. W. & Sood, A. K., 2012, In : Journal of Clinical Oncology. 30, 23, p. 2885-2890 6 p.

Research output: Contribution to journalArticle

88 Scopus citations

The role of LEF1 in endometrial gland formation and carcinogenesis

Shelton, D. N., Fornalik, H., Neff, T., Park, S. Y., Bender, D., DeGeest, K., Liu, X., Xie, W., Meyerholz, D. K., Engelhardt, J. F. & Goodheart, M. J., Jul 6 2012, In : PloS one. 7, 7, e40312.

Research output: Contribution to journalArticle

25 Scopus citations
2011

Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: A Gynecologic Oncology Group trial

Matei, D., Sill, M. W., Lankes, H. A., DeGeest, K., Bristow, R. E., Mutch, D., Yamada, S. D., Cohn, D., Calvert, V., Farley, J., Petricoin, E. F. & Birrer, M. J., Jan 1 2011, In : Journal of Clinical Oncology. 29, 1, p. 69-75 7 p.

Research output: Contribution to journalArticle

138 Scopus citations

A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies

Usha, L., Sill, M. W., Darcy, K. M., Benbrook, D. M., Hurteau, J. A., Michelin, D. P., Mannel, R. S., Hanjani, P., De Geest, K. & Godwin, A. K., Jun 1 2011, In : Gynecologic oncology. 121, 3, p. 455-461 7 p.

Research output: Contribution to journalArticle

36 Scopus citations

A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study (GOG 146Q)

Herzog, T. J., Sill, M. W., Walker, J. L., O'Malley, D., Shahin, M., Degeest, K., Weiner, S. A., Mutch, D., Debernardo, R. L. & Lentz, S. S., Mar 1 2011, In : Gynecologic oncology. 120, 3, p. 454-458 5 p.

Research output: Contribution to journalArticle

23 Scopus citations

A phase i study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study

Morgan, M. A., Sill, M. W., Fujiwara, K., Greer, B., Rubin, S. C., Degeest, K., Yamada, S. D., Waggoner, S., Coleman, R. L., Walker, J. L. & Mannel, R. S., May 1 2011, In : Gynecologic oncology. 121, 2, p. 264-268 5 p.

Research output: Contribution to journalArticle

15 Scopus citations

A randomized phase III trial of IV carboplatin and paclitaxel x 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: A Gynecologic Oncology Group Study

Mannel, R. S., Brady, M. F., Kohn, E. C., Hanjani, P., Hiura, M., Lee, R., DeGeest, K., Cohn, D. E., Monk, B. J. & Michael, H., Jul 1 2011, In : Gynecologic oncology. 122, 1, p. 89-94 6 p.

Research output: Contribution to journalArticle

47 Scopus citations

A single-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival

Shamshirsaz, A. A., Buekers, T., DeGeest, K., Bender, D., Zamba, G. & Goodheart, M. J., Oct 1 2011, In : International Journal of Gynecological Cancer. 21, 7, p. 1232-1240 9 p.

Research output: Contribution to journalArticle

7 Scopus citations

Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: A phase II study of the Gynecologic Oncology Group

Monk, B. J., Sill, M. W., Hanjani, P., Edwards, R., Rotmensch, J., De Geest, K., Bonebrake, A. J. & Walker, J. L., Mar 1 2011, In : Gynecologic oncology. 120, 3, p. 459-463 5 p.

Research output: Contribution to journalArticle

11 Scopus citations

Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients

Lutgendorf, S. K., DeGeest, K., Dahmoush, L., Farley, D., Penedo, F., Bender, D., Goodheart, M., Buekers, T. E., Mendez, L., Krueger, G., Clevenger, L., Lubaroff, D. M., Sood, A. K. & Cole, S. W., Feb 1 2011, In : Brain, Behavior, and Immunity. 25, 2, p. 250-255 6 p.

Research output: Contribution to journalArticle

94 Scopus citations
2010

Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis

Sood, A. K., Armaiz-Pena, G. N., Halder, J., Nick, A. M., Stone, R. L., Hu, W., Carroll, A. R., Spannuth, W. A., Deavers, M. T., Allen, J. K., Han, L. Y., Kamat, A. A., Shahzad, M. M. K., McIntyre, B. W., Diaz-Montero, C. M., Jennings, N. B., Lin, Y. G., Merritt, W. M., DeGeest, K., Vivas-Mejia, P. E. & 4 others, Lopez-Berestein, G., Schaller, M. D., Cole, S. W. & Lutgendorf, S. K., May 3 2010, In : Journal of Clinical Investigation. 120, 5, p. 1515-1523 9 p.

Research output: Contribution to journalArticle

164 Scopus citations

Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer

Weinrib, A. Z., Sephton, S. E., DeGeest, K., Penedo, F., Bender, D., Zimmerman, B., Kirschbaum, C., Sood, A. K., Lubaroff, D. M. & Lutgendorf, S. K., Sep 15 2010, In : Cancer. 116, 18, p. 4410-4419 10 p.

Research output: Contribution to journalArticle

62 Scopus citations

Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184

Cella, D., Huang, H., Homesley, H. D., Montag, A., Salani, R., De Geest, K., Lee, R. & Spirtos, N. M., Dec 1 2010, In : Gynecologic oncology. 119, 3, p. 538-542 5 p.

Research output: Contribution to journalArticle

19 Scopus citations

Phase II clinical trial of ixabepilone in patients with recurrent or persistent platinum- and taxane-resistant ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study

De Geest, K., Blessing, J. A., Morris, R. T., Yamada, S. D., Monk, B. J., Zweizig, S. L., Matei, D., Muller, C. Y. & Richards, W. E., Jan 1 2010, In : Journal of Clinical Oncology. 28, 1, p. 149-153 5 p.

Research output: Contribution to journalArticle

53 Scopus citations

Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: A gynecologic oncology group study

Powell, M. A., Filiaci, V. L., Rose, P. G., Mannel, R. S., Hanjani, P., DeGeest, K., Miller, B. E., Susumu, N. & Ueland, F. R., Jun 1 2010, In : Journal of Clinical Oncology. 28, 16, p. 2727-2731 5 p.

Research output: Contribution to journalArticle

114 Scopus citations

Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer

Han, E. S., Burger, R. A., Darcy, K. M., Sill, M. W., Randall, L. M., Chase, D., Parmakhtiar, B., Monk, B. J., Greer, B. E., Connelly, P., Degeest, K. & Fruehauf, J. P., Dec 1 2010, In : Gynecologic oncology. 119, 3, p. 484-490 7 p.

Research output: Contribution to journalArticle

49 Scopus citations

Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach

Lutgendorf, S. K., Mullen-Houser, E., Russell, D., DeGeest, K., Jacobson, G., Hart, L., Bender, D., Anderson, B., Buekers, T. E., Goodheart, M. J., Antoni, M. H., Sood, A. K. & Lubaroff, D. M., Nov 1 2010, In : Brain, Behavior, and Immunity. 24, 8, p. 1231-1240 10 p.

Research output: Contribution to journalArticle

38 Scopus citations

Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass

Nolen, B., Velikokhatnaya, L., Marrangoni, A., De Geest, K., Lomakin, A., Bast, R. C. & Lokshin, A., Jun 1 2010, In : Gynecologic oncology. 117, 3, p. 440-445 6 p.

Research output: Contribution to journalArticle

117 Scopus citations
2009

A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study

Aghajanian, C., Blessing, J. A., Darcy, K. M., Reid, G., DeGeest, K., Rubin, S. C., Mannel, R. S., Rotmensch, J., Schilder, R. J. & Riordan, W., Nov 1 2009, In : Gynecologic oncology. 115, 2, p. 215-220 6 p.

Research output: Contribution to journalArticle

43 Scopus citations

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

Homesley, H. D., Filiaci, V., Gibbons, S. K., Long, H. J., Cella, D., Spirtos, N. M., Morris, R. T., DeGeest, K., Lee, R. & Montag, A., Mar 1 2009, In : Gynecologic oncology. 112, 3, p. 543-552 10 p.

Research output: Contribution to journalArticle

146 Scopus citations

Depression, social support, and beta-adrenergic transcription control in human ovarian cancer

Lutgendorf, S. K., DeGeest, K., Sung, C. Y., Arevalo, J. M., Penedo, F., Lucci, J., Goodheart, M., Lubaroff, D., Farley, D. M., Sood, A. K. & Cole, S. W., Feb 1 2009, In : Brain, Behavior, and Immunity. 23, 2, p. 176-183 8 p.

Research output: Contribution to journalArticle

113 Scopus citations

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: A phase III trial of the gynecologic cancer intergroup

Bookman, M. A., Brady, M. F., McGuire, W. P., Harper, P. G., Alberts, D. S., Friedlander, M., Colombo, N., Fowler, J. M., Argenta, P. A., De Geest, K., Mutch, D. G., Burger, R. A., Swart, A. M., Trimble, E. L., Accario-Winslow, C. & Roth, L. M., Mar 20 2009, In : Journal of Clinical Oncology. 27, 9, p. 1419-1425 7 p.

Research output: Contribution to journalArticle

496 Scopus citations

Glucose as a prognostic factor in ovarian carcinoma

Lamkin, D. M., Spitz, D. R., Shahzad, M. M. K., Zimmerman, B., Lenihan, D. J., Degeest, K., Lubaroff, D. M., Shinn, E. H., Sood, A. K. & Lutgendorf, S. K., Mar 1 2009, In : Cancer. 115, 5, p. 1021-1027 7 p.

Research output: Contribution to journalArticle

36 Scopus citations
2008

Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma

Lutgendorf, S. K., Lamkin, D. M., Jennings, N. B., Arevalo, J. M. G., Penedo, F., DeGeest, K., Langley, R. R., Lucci, J. A., Cole, S. W., Lubaroff, D. M. & Sood, A. K., Nov 1 2008, In : Clinical Cancer Research. 14, 21, p. 6839-6846 8 p.

Research output: Contribution to journalArticle

99 Scopus citations

Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients

Lutgendorf, S. K., Lamkin, D. M., DeGeest, K., Anderson, B., Dao, M., McGinn, S., Zimmerman, B., Maiseri, H., Sood, A. K. & Lubaroff, D. M., Aug 1 2008, In : Brain, Behavior, and Immunity. 22, 6, p. 890-900 11 p.

Research output: Contribution to journalArticle

48 Scopus citations

Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth

Merritt, W. M., Lin, Y. G., Spannuth, W. A., Fletcher, M. S., Kamat, A. A., Han, L. Y., Landen, C. N., Jennings, N., De Geest, K., Langley, R. R., Villares, G., Sanguino, A., Lutgendorf, S. K., Lopez-Berestein, G., Bar-Eli, M. M. & Sood, A. K., Mar 2008, In : Journal of the National Cancer Institute. 100, 5, p. 359-372 14 p.

Research output: Contribution to journalArticle

197 Scopus citations

Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study

Hensley, M. L., Blessing, J. A., DeGeest, K., Abulafia, O., Rose, P. G. & Homesley, H. D., Jun 1 2008, In : Gynecologic oncology. 109, 3, p. 323-328 6 p.

Research output: Contribution to journalArticle

181 Scopus citations

HLA class i antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma

Han, L., Fletcher, M. S., Urbauer, D. L., Mueller, P., Landen, C. N., Kamat, A. A., Lin, Y. G., Merritt, W. M., Spannuth, W. A., Deavers, M. T., De Geest, K., Gershenson, D. M., Lutgendorf, S. K., Ferrone, S. & Sood, A. K., Jun 1 2008, In : Clinical Cancer Research. 14, 11, p. 3372-3379 8 p.

Research output: Contribution to journalArticle

100 Scopus citations

Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients

Lutgendorf, S. K., Weinrib, A. Z., Penedo, F., Russell, D., DeGeest, K., Costanzo, E. S., Henderson, P. J., Sephton, S. E., Rohleder, N., Lucci, J. A., Cole, S., Sood, A. K. & Lubaroff, D. M., Oct 10 2008, In : Journal of Clinical Oncology. 26, 29, p. 4820-4827 8 p.

Research output: Contribution to journalArticle

116 Scopus citations

Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: A phase I and feasibility trial of the Gynecologic Oncology Group

Morgan, M. A., Darcy, K. M., Rose, P. G., DeGeest, K., Bookman, M. A., Aikins, J. K., Sill, M. W., Mannel, R. S., Allievi, C. & Egorin, M. J., Sep 1 2008, In : Gynecologic oncology. 110, 3, p. 329-335 7 p.

Research output: Contribution to journalArticle

22 Scopus citations

Positive psychosocial factors and NKT cells in ovarian cancer patients

Lamkin, D. M., Lutgendorf, S. K., McGinn, S., Dao, M., Maiseri, H., DeGeest, K., Sood, A. K. & Lubaroff, D. M., Jan 1 2008, In : Brain, Behavior, and Immunity. 22, 1, p. 65-73 9 p.

Research output: Contribution to journalArticle

15 Scopus citations

The impact of surgery on survival of elderly women with endometrial cancer in the SEER program from 1992-2002

Ahmed, A., Zamba, G., DeGeest, K. & Lynch, C. F., Oct 1 2008, In : Gynecologic oncology. 111, 1, p. 35-40 6 p.

Research output: Contribution to journalArticle

49 Scopus citations